Bee Vectoring Technologies Announces a Second Year of Successful Seed Treatment Trial Results

About this update from Bee Vectoring Technologies International, Inc.

[{"type":"text","content":"Bee Vectoring Technologies Announces a Second Year of Successful Seed Treatment Trial ResultsConsistently increased crop yields and outperformed base seed treatmentLarger, healthier soybean plants; more biomass and higher plant vigorConsistent, repeating positive results to add to successful first year trialsMississauga, Ontario and Sacramento, California--(Newsfile Corp. - March 7, 2023) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the \"Company\" or \"BVT\") is pleased to announce positive second year trial results demonstrating the efficacy of BVT's proprietary biological control agent Clonostachys rosea strain CR-7 (CR-7) as a seed treatment on soybeans.Compared to the first-year trials, the second-year included measuring CR-7's effect on soybean yields. Year 2 trial data established that adding CR-7 over base seed treatment results in soybean plants producing higher yields as measured over 16 replicated plots across four locations when compared to the biological standard, and that CR-7 was equivalent to the chemical standard in terms of effectiveness. Other measures on plant health, vigor and plant biomass showed the same positive outcomes as in the first year, indicating the scalability of BVT's proprietary CR-7 in the soybean seed treatment market.\"Wherever CR-7 was applied, the results outperformed the base seed treatment 81% of the time. We observed, on average, a three-bushel yield per acre increase with CR-7 added, which is about 4% higher than the base seed treatment. Although that may not sound dramatic, that is a meaningful improvement for a treatment that was applied at the very early stages of the planting season. Most seed treatments are designed to protect the seed from pests, but to see a positive increase in the yield at the end of the season is impressive,\" said Dr. Mason Newark, Field Technical Manager at BVT.Year 1 and 2 trials were conducted in partnership with well-established soybean researchers in Iowa, Illinois, and Wisconsin, with a fourth location in Nebraska added in 2022 and resulted in consistently positive results year over year across all the states that have had trials so far. The 2022 trials continued assessing the efficacy of CR-7 added over base seed treatment on plant biomass and vigor, and demonstrated its effectiveness as a treatment against dis...

More updates from Bee Vectoring Technologies International, Inc.